
Baxter International BAX
$ 17.56
2.42%
Annual report 2025
added 02-12-2026
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
Shares |
513 M |
Market Cap[1] |
$ 9.01 B |
EBITDA (LTM) |
$ 1.11 B |
P/E (LTM) |
28.11 |
P/S (LTM) |
0.8 |
EPS (LTM) |
0.61 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
$ 28.42 | 0.67 % | $ 1.36 B | Nasdaq Global Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 59.45 | 3.74 % | $ 2.99 B | NYSE,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 79.49 | 1.9 % | $ 40.4 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 9.23 | 2.27 % | $ 22.4 M | Nasdaq Capital Market | ||
|
The Cooper Companies
COO
|
$ 71.54 | 0.46 % | $ 14.2 B | NYSE,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.32 | 2.61 % | $ 200 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.38 | -8.3 % | $ 109 M | Nasdaq Global Select Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Harvard Bioscience
HBIO
|
$ 4.71 | 9.16 % | $ 209 M | Nasdaq Global Market | ||
|
electroCore
ECOR
|
$ 6.31 | 3.78 % | $ 53.5 K | Nasdaq Global Select Market | ||
|
Masimo Corporation
MASI
|
$ 178.34 | 0.01 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 26.77 | 1.4 % | $ 4.5 B | NYSE | ||
|
Pro-Dex
PDEX
|
$ 51.99 | 0.99 % | $ 171 M | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 118.72 | 3.02 % | $ 3.8 B | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Milestone Scientific
MLSS
|
$ 0.3 | 6.69 % | $ 24.6 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 70.5 | 3.28 % | $ 4.17 B | Nasdaq Global Select Market,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 118.42 | 1.68 % | $ 5.74 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.7 | 3.72 % | $ 21 M | NYSE American | ||
|
ICU Medical
ICUI
|
$ 127.21 | 1.22 % | $ 3.13 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.67 | 3.09 % | $ 200 M | NYSE American | ||
|
STERIS plc
STE
|
$ 223.0 | 0.2 % | $ 22 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 121.75 | 2.81 % | $ 5.43 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 66.5 | 0.91 % | $ 215 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 455.87 | 1.17 % | $ 163 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 114.19 | -0.38 % | $ 2.59 B | Nasdaq Global Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.94 | 1.96 % | $ 2.38 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 20.18 | 2.2 % | $ 930 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 229.35 | 0.27 % | $ 33.5 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 19.11 | 2.33 % | $ 1.29 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.94 | 3.74 % | $ 176 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 26.86 | 1.57 % | $ 1.33 B | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 257.23 | 0.28 % | $ 18.6 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 10.1 | 3.06 % | $ 413 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 155.04 | 0.59 % | $ 44.6 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 2.92 | -1.35 % | $ 30.3 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.09 | 4.22 % | $ 227 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 122.11 | 1.67 % | $ 6.8 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.